SCHEMBL20615329

SCHEMBL20615329

C=Cc1ccc2c(c1)OCCN2CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.39
PGR P06401 1/20 0.39
AR P10275 1/20 0.39
GRM5 P41594 2/20 0.36
PTGER3 P43115 3/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
SRD5A1 P18405 1/20 0.33
HTR1A P08908 1/20 0.33
SLC6A4 P31645 1/20 0.33
NOS2 P35228 1/20 0.32
KCNH2 Q12809 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPC1 O15118 1/20 0.32
APOBEC3A P31941 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11143387 0.85 ALDH1A1 (0.42) NR3C1PGRARGRM5PTGER3
SCHEMBL21872800 0.80 CYP11B1 (0.48) ARGRM5PTGER3ALDH1A1L3MBTL1
SCHEMBL13180252 0.78 NR3C1 (0.42) NR3C1PGRARGRM5PTGER3
SCHEMBL20116440 0.77 LMNA (0.42) NR3C1PGRARGRM5PTGER3
SCHEMBL30506313 0.77 LMNA (0.42) NR3C1PGRARGRM5PTGER3
SCHEMBL24826392 0.77 NR3C1 (0.44) NR3C1PGRARGRM5PTGER3
SCHEMBL13180185 0.77 NPY5R (0.45) NR3C1PGRARGRM5PTGER3
SCHEMBL5516550 0.77 NR3C1 (0.41) NR3C1PGRARGRM5PTGER3
SCHEMBL14349663 0.75 NR3C1 (0.40) NR3C1PGRARGRM5PTGER3
SCHEMBL27308881 0.75 PTGER3 (0.44) NR3C1PGRARGRM5PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019004970-A2 HETEROBIVALENT LIGANDS SUITABLE FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE T.C. İSTANBUL MEDİPOL ÜNİVERSİTESİ (TR) 2019-01-03 WO disclosed